Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Humira Pen(Adalimumab)AbbVie Inc. logoABBV

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by AbbVie Inc.

$697.1M

Medicare cost, 2024

Medicare drug plans spent $697.1 million on Humira Pen (adalimumab) in 2024, for 85,133 prescriptions and refills filled by 11,715 patients. It ranks 72nd among all drugs by Medicare drug plan spending. Spending fell 16% from 2023 to 2024. At about $8,188 per prescription it is a high-cost drug.

Medicare cost, 2024

$697.1M

-16.5% from 2023

Prescriptions

85K

$8,187.97 per claim

Patients

12K

8,920 prescribers

Total spending, 2024

$697.4M

$59,510.64 per patient

Questions and answers

How much does Medicare spend on Humira Pen?

Medicare prescription drug plans paid $697.1M for Humira Pen in 2024, for 85,133 prescriptions and refills to 11,715 patients (down 16.5% from 2023). The average cost per claim was $8,187.97.

Which state spends the most on Humira Pen?

California had the highest Medicare cost for Humira Pen in 2024: $72.7M for 9,423 claims, followed by New York ($44.1M).

Who prescribes Humira Pen the most?

Charles King, rheumatology in Tupelo, MS, had the highest Medicare cost for Humira Pen in 2024: 744 claims costing $5.1M.

Who makes Humira Pen?

Humira Pen is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Humira Pen was $697.4M in 2024, after a high of $1.22B in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Humira Pen, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Charles King Tupelo, MSRheumatology744110$5.1M
David M Pugliese Wilkes Barre, PARheumatology22138$1.8M
Ramachandran Srinivasan Monterey Park, CARheumatology25336$1.6M
Jason N Schairer Novi, MIGastroenterology16416$1.5M
Christy C Park Knoxville, TNRheumatology20323$1.4M
Srikanth Naramala Visalia, CARheumatology20533$1.4M
Yolanda Lopez-Lopez Bayamon, PRRheumatology17921$1.3M
Jennifer Burkham San Jose, CARheumatology17119$1.2M
Ahmad Ramahi Roswell, NMRheumatology15118$1.2M
Luisana Gomez Monterey Park, CAPhysician Assistant16130$1.0M
Brianna D Cornett Cumberland, KYNurse Practitioner15834$1.0M
Travis C Sizemore Simpsonville, SCRheumatology14324$1.0M
Rashad Ansari Vista, CARheumatology15013$994K
Sathish Kumar Itikyala West Plains, MOInternal Medicine13526$989K
Maosong Qi Lawrence, MARheumatology11814$971K
Walter E James IV Charleston, SCPulmonary Disease8611$970K
Jeffrey D Ryan-Stout Grand Rapids, MIPhysician Assistant11411$933K
Brian P Oppermann State College, PARheumatology13120$923K
Birju Bhatt Wilkes Barre, PARheumatology11921$888K
Mary E Margaretten San Francisco, CARheumatology8712$877K
Laura D Aspey Atlanta, GADermatology8914$832K
Robert M Gay Jr. Winston Salem, NCRheumatology94Under 11$826K
Duncan Fagundus Greenville, NCPediatric Medicine10412$783K
Aixa E Toledo-Garcia Albany, NYRheumatology54Under 11$776K
Marcin A Trojanowski Boston, MARheumatology9614$763K

Prescriber data by year

YearPrescribersClaimsPatientsCost
202211,372116,99915,674$914.0M
202310,23197,88513,630$834.7M
20248,92085,13311,715$697.1M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Abbvie US LLCABBV logoABBV85,167$697.4M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube